Talal AH - Search Results

1

A framework for patient-centered telemedicine: Application and lessons learned from vulnerable populations.

Talal AH, Sofikitou EM, Jaanimägi U, Zeremski M, Tobin JN, Markatou M. Talal AH, et al. J Biomed Inform. 2020 Dec;112:103622. doi: 10.1016/j.jbi.2020.103622. Epub 2020 Nov 10. J Biomed Inform. 2020. PMID: 33186707 Free article.

2

Virus dynamics and immune responses during treatment in patients coinfected with hepatitis C and HIV.

Talal AH, Shata MT, Markatou M, Dorante G, Chadburn A, Koch R, Neumann AU, Ribeiro RM, Perelson AS. Talal AH, et al. J Acquir Immune Defic Syndr. 2004 Feb 1;35(2):103-13. doi: 10.1097/00126334-200402010-00001. J Acquir Immune Defic Syndr. 2004. PMID: 14722440

3

Noninvasive markers of hepatic fibrosis: are they ready for prime time in the management of HIV/HCV co-infected patients?

Zeremski M, Talal AH. Zeremski M, et al. Among authors: talal ah. J Hepatol. 2005 Jul;43(1):2-5. doi: 10.1016/j.jhep.2005.05.007. J Hepatol. 2005. PMID: 15922482 Review. No abstract available.

4

Pharmacodynamics of PEG-IFN alpha differentiate HIV/HCV coinfected sustained virological responders from nonresponders.

Talal AH, Ribeiro RM, Powers KA, Grace M, Cullen C, Hussain M, Markatou M, Perelson AS. Talal AH, et al. Hepatology. 2006 May;43(5):943-53. doi: 10.1002/hep.21136. Hepatology. 2006. PMID: 16761329

5

Dideoxynucleoside analogues should be used cautiously in patients with hepatic steatosis.

Zeremski M, Talal AH. Zeremski M, et al. Among authors: talal ah. Clin Infect Dis. 2006 Aug 1;43(3):373-6. doi: 10.1086/505501. Epub 2006 Jun 22. Clin Infect Dis. 2006. PMID: 16804854 No abstract available.

6

Early ribavirin pharmacokinetics, HCV RNA and alanine aminotransferase kinetics in HIV/HCV co-infected patients during treatment with pegylated interferon and ribavirin.

Dahari H, Markatou M, Zeremski M, Haller I, Ribeiro RM, Licholai T, Perelson AS, Talal AH. Dahari H, et al. Among authors: talal ah. J Hepatol. 2007 Jul;47(1):23-30. doi: 10.1016/j.jhep.2007.01.027. Epub 2007 Feb 22. J Hepatol. 2007. PMID: 17412448 Free PMC article. Clinical Trial.

7

Interferon gamma-inducible protein 10: a predictive marker of successful treatment response in hepatitis C virus/HIV-coinfected patients.

Zeremski M, Markatou M, Brown QB, Dorante G, Cunningham-Rundles S, Talal AH. Zeremski M, et al. Among authors: talal ah. J Acquir Immune Defic Syndr. 2007 Jul 1;45(3):262-8. doi: 10.1097/QAI.0b013e3180559219. J Acquir Immune Defic Syndr. 2007. PMID: 17414926 Clinical Trial.

8

The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.

Zeremski M, Petrovic LM, Talal AH. Zeremski M, et al. Among authors: talal ah. J Viral Hepat. 2007 Oct;14(10):675-87. doi: 10.1111/j.1365-2893.2006.00838.x. J Viral Hepat. 2007. PMID: 17875002 Review.

9

Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users.

Zeremski M, Shu MA, Brown Q, Wu Y, Des Jarlais DC, Busch MP, Talal AH, Edlin BR. Zeremski M, et al. Among authors: talal ah. J Viral Hepat. 2009 Jan;16(1):10-20. doi: 10.1111/j.1365-2893.2008.01016.x. Epub 2008 Jul 17. J Viral Hepat. 2009. PMID: 18647233 Free PMC article.

10

Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C.

Zeremski M, Petrovic LM, Chiriboga L, Brown QB, Yee HT, Kinkhabwala M, Jacobson IM, Dimova R, Markatou M, Talal AH. Zeremski M, et al. Among authors: talal ah. Hepatology. 2008 Nov;48(5):1440-50. doi: 10.1002/hep.22500. Hepatology. 2008. PMID: 18798334 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters